California settles opioid lawsuit with same company selling the state overdose meds

Amneal Pharmaceuticals settled a multi-state lawsuit alleging it contributed to the opioid crisis in the same week that it struck a deal to sell overdose reversal medication to California at a discounted rated. Here, Amneal Pharmaceuticals prescription pharmaceutical packaging sits in a pharmacy in Remington, Virginia on Feb. 26, 2019.

In a statement, Amneal said the settlement would resolve all pending lawsuits filed by states against the company.The company did not admit any wrongdoing. To date, California has secured $4.25 billion in opioid settlement funds from drug companies for their alleged role in fueling the opioid epidemic. The state uses the money on opioid remediation programs, such as distributing naloxone and training substance use providers.Since 2018, the state has been purchasing the overdose reversal medication and distributing it to schools, law enforcement, county health departments and community harm reduction programs.

المملكة العربية السعودية أحدث الأخبار, المملكة العربية السعودية عناوين

Similar News:يمكنك أيضًا قراءة قصص إخبارية مشابهة لهذه التي قمنا بجمعها من مصادر إخبارية أخرى.

California is joining with a New Jersey company to buy a generic opioid overdose reversal drugAmneal Pharmaceuticals will sell naloxone to California for $24 per pack, or about 40% cheaper than the market rate. California will give away the packs for free to first responders, universities a…
مصدر: mercnews - 🏆 88. / 68 اقرأ أكثر »